NAD Fills Regulatory “Void” In Setting Advertising Standards
This article was originally published in The Tan Sheet
Executive Summary
NAD decisions reference FDA and Federal Trade Commission regulations while establishing standards for advertising claims, says senior attorney Kathleen Dunnigan. “What we really do is we fill a void which is to set advertising standards and to try to get truthful and accurate claims,” she says at FDLI’s annual conference.
You may also be interested in...
J&J Fights NAD Neutrogena Decision Assailing Sunscreen “Barrier”
In a challenge brought by Coppertone sunscreen products marketer Merck & Co., NAD reviews claims for Neutrogena in print, online and in-store advertising, as well as on packaging for Neutrogena Beach Defense lotion and spray. J&J argues its claim uses same term as FDA’s online “Sun Protection” page.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.